<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="127836">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02014675</url>
  </required_header>
  <id_info>
    <org_study_id>67 (TA108)</org_study_id>
    <nct_id>NCT02014675</nct_id>
  </id_info>
  <brief_title>SD01 Registry (SD01 ICD Lead)</brief_title>
  <acronym>SD01 Registry</acronym>
  <official_title>SD01 Registry (SD01 ICD Lead)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Biotronik SE &amp; Co. KG</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Biotronik SE &amp; Co. KG</source>
  <oversight_info>
    <authority>Germany: Ethics Comittee</authority>
    <authority>Italy: Ethics Committee</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This registry is designed to gather further evidence, in addition to the SD01 Master Study,
      for the safety and efficacy of the SD01 ICD lead.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>March 2014</start_date>
  <completion_date type="Anticipated">April 2020</completion_date>
  <primary_completion_date type="Anticipated">April 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational [Patient Registry]</study_type>
  <study_design>Observational Model: Case-Only, Time Perspective: Prospective</study_design>
  <target_duration>5 Years</target_duration>
  <primary_outcome>
    <measure>SADE-free rate</measure>
    <time_frame>5 years</time_frame>
    <safety_issue>Yes</safety_issue>
  </primary_outcome>
  <other_outcome>
    <measure>Pacing threshold of SD01</measure>
    <time_frame>3-month follow-up</time_frame>
    <safety_issue>No</safety_issue>
  </other_outcome>
  <other_outcome>
    <measure>Sensing amplitude of SD01</measure>
    <time_frame>3-month follow-up</time_frame>
    <safety_issue>No</safety_issue>
  </other_outcome>
  <other_outcome>
    <measure>Device deficiencies</measure>
    <time_frame>5 years</time_frame>
    <safety_issue>Yes</safety_issue>
  </other_outcome>
  <other_outcome>
    <measure>Long-term pacing impedance, pacing threshold, sensing amplitude and painless shock impedance of SD01 and other leads, if applicable</measure>
    <time_frame>5 years</time_frame>
    <safety_issue>No</safety_issue>
  </other_outcome>
  <other_outcome>
    <measure>Analysis of arrhythmias and their treatment</measure>
    <time_frame>until 3-month follow-up</time_frame>
    <safety_issue>Yes</safety_issue>
  </other_outcome>
  <other_outcome>
    <measure>ICD/CRT-D system performance</measure>
    <time_frame>5 years</time_frame>
    <safety_issue>No</safety_issue>
  </other_outcome>
  <other_outcome>
    <measure>SD01 implantation information, handling and operation time record</measure>
    <time_frame>Implantation</time_frame>
    <safety_issue>No</safety_issue>
  </other_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">280</enrollment>
  <condition>Ventricular Fibrillation</condition>
  <condition>Ventricular Tachycardia</condition>
  <condition>Heart Failure</condition>
  <arm_group>
    <arm_group_label>SD01 ICD lead</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>SD01 ICD lead</intervention_name>
    <arm_group_label>SD01 ICD lead</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with standard ICD/CRT-D (cardiac resynchronization therapy plus defibrillator)
        indication
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Meet a standard indication for ICD/CRT-D therapy

          -  First ICD/CRT-D implantation or upgrade from pacemaker

          -  Signed informed consent form

          -  Willing to participate for the whole duration of the registry

          -  Patient accepts Home Monitoring concept and is able to activate and use the
             Cardiomessenger

          -  Patient has legal capacity and ability to consent

        Exclusion Criteria:

          -  Meet a standard contraindication for an ICD/CRT-D therapy

          -  Age &lt;18 years

          -  Pregnant or breast-feeding women

          -  Cardiac surgery planned within the next six months

          -  Enrollment in another cardiac clinical investigation with active treatment arm

          -  Mechanical tricuspid valve prosthesis or severe tricuspid valve disease

          -  Dexamethasone acetate intolerance
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Jens Buttgereit, Dr.</last_name>
    <phone>+49 30 68905</phone>
    <phone_ext>1267</phone_ext>
    <email>jens.buttgereit@biotronik.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>University Clinic of Schleswig-Holstein</name>
      <address>
        <city>LÃ¼beck</city>
        <zip>23538</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Frank Bode, PD Dr. med.</last_name>
    </contact>
    <investigator>
      <last_name>Frank Bode, PD Dr. med.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>March 2014</verification_date>
  <lastchanged_date>March 13, 2014</lastchanged_date>
  <firstreceived_date>December 4, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>ICD</keyword>
  <keyword>CRT-D</keyword>
  <keyword>Lead</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Heart Failure</mesh_term>
    <mesh_term>Tachycardia</mesh_term>
    <mesh_term>Ventricular Fibrillation</mesh_term>
    <mesh_term>Tachycardia, Ventricular</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
